








Quarterly Report of Formulary Changes  
for 2nd Quarter 2019  














Janet T. Mills                  Anne L. Head 
Governor                 Commissioner 
 
 




Quarterly Report of Insurance Carrier Formulary Changes for Q2 
Second Quarter 2019  




Pursuant to P.L. 2017, ch. 429, the Bureau of Insurance is required to report to the Maine Legislature’s 
Committee on Health Coverage, Insurance and Financial Services on any changes made by carriers, or 
any Pharmacy Benefits Manager contracted by carriers, to any prescription drug formulary for a health 
plan offered between January 1, 2019 and December 31, 2019.  
 
24-A M.R.S. § 4311 B-1 states: 
Sec. B-1. Report on formulary changes. As determined by the Department of Professional and 
Financial Regulation, Bureau of Insurance, a carrier subject to the requirements of the Maine 
Revised Statutes, Title 24-A, section 4311, subsection 1 shall report quarterly no less than 30 
days following the end of each quarter on any changes made by the carrier or any pharmacy 
benefits manager contracted by the carrier to any prescription drug formulary for a health plan 
offered in this State between January 1, 2019 and December 31, 2019. For purposes of this 
section, a change to a prescription drug formulary includes the movement of a prescription drug 
to a tier with higher cost sharing for that drug or the removal of a prescription drug from the 
formulary. The report must be in a form and manner determined by the Bureau of Insurance and 
include a list of formulary changes made by the carrier and the effective date of each formulary 
change; the prescription drugs affected by each formulary change by name and manufacturer; 
the number of enrollees affected by each formulary change; the expected impact of each 
formulary change on cost sharing for affected enrollees; a written explanation of the reasons for 
each formulary change; the number of exception requests made by enrollees with regard to each 
formulary change; and the number of exception requests granted, denied or withdrawn with 
regard to each formulary change.  (Emphasis added.)  No less than 60 days following the end of 
each quarter, as determined by the Bureau of Insurance, the bureau shall compile this data for 
those carriers required by the bureau to report and submit a report to the joint standing 
committee of the Legislature having jurisdiction over insurance and financial services matters. 
The joint standing committee of the Legislature having jurisdiction over insurance and financial 
services matters may report out legislation related to the report to any regular or special session 
of the 129th Legislature. 
 
The information published in this report is based upon the self-reported data furnished by insurance 
companies to the Bureau of Insurance.   All carriers that use a formulary were surveyed.  This included 
the 6 largest carriers in Maine and the largest prescription TPA:  Anthem, Aetna, Community Health 
Options, Cigna, Harvard Pilgrim/HPHC, United and Express Scripts.  Those carriers, the Bureau of 
Insurance and the State of Maine Employee Health Benefits Department worked together to develop 
the form used to gather the required data.  
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Summary for the second quarter of 2019: 
 
• 329 drugs were subject to formulary changes (excluding duplicative drugs due to various 
dosages or dispensing type, there are 173 drugs). 
 
• Approximately half the changes were to add new drugs.  15% were to remove drugs. 
 
• These changes affected 2,886 enrollees.   
 
• Of these enrollees, 5% (151) filed for exceptions.  67% were granted; 32% were denied; 
1% were withdrawn. 
 
• 46% of enrollees were impacted by lower or no change in cost; 46% by higher costs and 
54% by higher costs IF they continued use of the drug that was removed from 
formulary. 
Table 1:  Changes made on the 329 drugs listed for Q2 2019 
Change Made Number of Drugs Affected 
Add drugs  172 
Remove drugs 48 
Add prior authorization 16 
Remove prior authorization 12 
Move drug to higher tier 35 
Add quantity limit 11 
Add step therapy 7 
Move drug to lower tier 21 
Drug becomes over the counter 0 
Decrease quantity limit 7 
Total 329 
 
Table 2:  Top drugs changed for Q2 2019    
Drug Number of Changes 
Ambrisentan 28 
Flovent 19 
Healthwise Insulin Syringes and Pen Needle 13 
 
Ambrisentan is used to treat high blood pressure in the lungs (pulmonary arterial hypertension). This 
condition is thought to be caused by increased levels of a certain natural substance (endothelin-1). This 
medication blocks the effects of endothelin-1, thereby helping to decrease the blood pressure in the 




Flovent or Fluticasone is used to control and prevent symptoms (such as wheezing and shortness of 
breath) caused by asthma. It works by reducing swelling (inflammation) of the airways in the lungs to 
make breathing easier. Controlling symptoms of asthma helps maintain normal activities and decreases 
time lost from work or school. Fluticasone belongs to a class of drugs known as corticosteroids.  This 
medication must be used regularly to be effective.  
 
Healthwise Insulin syringes and pen needles are a specific brand used to administer insulin to control 
diabetes.  
 
Table 3:  Number of enrollees affected by changes during Q2 2019 
Change Number of Affected Enrollees 
Add drugs 756 
Remove drugs 348 
Add prior authorization 1 
Remove prior authorization 87 
Move drug to higher tier 1208 
Add quantity limit 0 
Add step therapy 4 
Move drug to lower tier 465 
Drug becomes over the counter 0 
Decrease quantity limit 17 
Total  2886 
 
Table 4:  Expected impact and the number of enrollees affected by the impact for Q2 2019 
Expected Impact Number of Affected Enrollees 
Responsible for full cost of drug * 242 
No change 391 
Higher cost 1317 
Lower cost 936 
Total 2886 
 
*Results from removal of drug from formulary, which could result in higher cost to enrollee if they do not 
change to a different drug. 
 
46% of enrollees are impacted by lower or no change in cost 
46% of enrollees are impacted by higher costs or 





Table 5:  Number of enrollees affected by the formulary changes, number of exceptions 
requested, granted, denied and withdrawn  










2886 151 102 48 1 
 
5% of all enrollees affected filed for exceptions: 
68% granted, 32% denied 
 
Table 6:  Number of exceptions granted and denied by change made in Q2 2019 
Change Made Granted  Denied Withdrawn 
Add drugs 54 30  
Remove drugs 16 6  
Add prior authorization 1 0  
Move drug to higher tier 0 0  
Remove prior authorization 3 3  
Add step therapy 3 0  
Move drug to lower tier 24 9  
Drug becomes over the counter 0 0  
Decrease quantity limit 1 0 1 
Total 102 48 1 
 
 
Table 7:  Reasons given by carriers for the changes for Q2 2019. 
Formulary Change Reasons  Total Drugs per Reason 
Added Upon Release to Market  377 
Business Decision Team Decision-generic equivalent  183 
To ensure clinically appropriate usage of drug  107 
Business Decision Team Decision to exclude drug from formulary  30 
Business Decision Team Decision to add Prior Authorization  27 
Business Decision Team Decision to add Quantity Limits  18 
To ensure clinically appropriate dosage of drug  55 
Additional therapy option for enrollees  47 
Generic version approved and added at lower tier  47 
Clinically appropriate alternatives on formulary   20 
Lower cost option for enrollees  98 
AB rated (therapeutically equivalent) substitutable  20 
Medication not approved by FDA as a drug  13 
Business Decision Team Decision to remove Prior Authorization  5 
Multisource brand (MSB) removal  3 
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Formulary Change Reasons  Total Drugs per Reason 
Promote appropriate use and minimize overuse/waste  8 
Anesthesia medication that must be administered by MD  1 
To encourage appropriate use of preferred agents  19 
Cosmetic use/not covered  1 
Total  1079 
Table 8:  Changes Made by Drug Name Q2 2019   
Drug Name Change Made 
TRACLEER 62.5MG MOVE DRUG TO HIGHER TIER 
ACCU-CHEK GUIDE ME GLUCOSE MTR ADD DRUGS 
ACTEMRA (TOCILIZUMAB) 162 MG/0.9 ML ACTPEN PREFILLED 
AUTOINJECTOR 
ADD STEP THERAPY 
ADAPALENE 0.1% SWAB ADD DRUGS 
ADDERALL XR REMOVE DRUGS 
ADVAIR 100-50 DISKUS MOVE DRUG TO HIGHER TIER 
ADVAIR 100-50 DISKUS REMOVE DRUGS 
ADVAIR 100-50, 250-50 DISKUS REMOVE DRUGS 
ADVAIR 250-50 DISKUS MOVE DRUG TO HIGHER TIER 
ADVAIR 250-50 DISKUS REMOVE DRUGS 
ADVAIR 500-50 DISKUS MOVE DRUG TO HIGHER TIER 
ADVAIR 500-50 DISKUS REMOVE DRUGS 
AEMCOLO ADD QUANTITY LIMIT 
AG HUMALOG (INSULIN LISPRO) ADD DRUGS 
AIMOVIG      INJ 140DOSE DECREASE QUANTITY LIMIT 
AIMOVIG      INJ 70MG/ML DECREASE QUANTITY LIMIT 
AIMOVIG 140 MG DOSE-2 AUTOINJ ADD DRUGS 
AIMOVIG 140 MG/ML AUTOINJECTOR ADD DRUGS 
AIMOVIG 70 MG/ML AUTOINJECTOR ADD DRUGS 
ALBUTEROL HFA 90 MCG INHALER ADD DRUGS 
ALBUTEROL SUL HFA 90 MCG INH MOVE DRUG TO LOWER TIER 
AMBRISENTAN 10 MG TABLET ADD DRUGS 
AMBRISENTAN 5 MG TABLET ADD DRUGS 
ANTICOAG SODIUM CITRATE 4% SYR ADD DRUGS 
APADAZ ADD PRIOR AUTHORIZATION 
APADAZ REMOVE PRIOR AUTHORIZATION 
APRIZIO PAK ADD DRUGS 
ARIKAYCE ADD PRIOR AUTHORIZATION 
ASMANEX TWISTHALER DECREASE QUANTITY LIMIT 
ATRIPLA ADD STEP THERAPY 
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AUROVELA 1 MG-20 MCG TABLET ADD DRUGS 
AUROVELA 21 1.5-30 TABLET ADD DRUGS 
AUROVELA 24 FE 1 MG-20 MCG TAB ADD DRUGS 
AUROVELA FE 1-20 TABLET ADD DRUGS 
AVENOVA REMOVE DRUGS 
AVENOVA NEUTROX REMOVE DRUGS 
AZESCO TABLET ADD DRUGS 
BALVERSA 3 MG TABLET ADD DRUGS 
BALVERSA 4 MG TABLET ADD DRUGS 
BALVERSA 5 MG TABLET ADD DRUGS 
BD NANO 2 GEN PEN NDL 32GX4MM ADD DRUGS 
BELRAPZO 100 MG/4 ML VIAL ADD DRUGS 
BESER 0.05% LOTION ADD DRUGS 
BIJUVA ADD PRIOR AUTHORIZATION 
BIJUVA ADD QUANTITY LIMIT 
BOSENTAN 125 MG TABLET ADD DRUGS 
BOSENTAN 62.5 MG TABLET ADD DRUGS 
BUTORPHANOL 10 MG/ML SPRAY REMOVE PRIOR AUTHORIZATION 
CANASA 1,000 MG SUPPOSITORY MOVE DRUG TO HIGHER TIER 
CANASA 1,000 MG SUPPOSITORY REMOVE DRUGS 
CARAFATE 1 GM/10 ML SUSP MOVE DRUG TO LOWER TIER 
CEFIXIME 400 MG CAPSULE ADD DRUGS 
CEQUA ADD QUANTITY LIMIT 
CHLORZOXAZONE 375 MG TABLET ADD DRUGS 
CHLORZOXAZONE 375 MG, 750 MG TABLET ADD DRUGS 
CHLORZOXAZONE 750 MG TABLET ADD DRUGS 
CHORIONIC GONAD 12,000 UNIT VL ADD DRUGS 
CHORIONIC GONAD 6,000 UNIT VL ADD DRUGS 
CIPRODEX OTIC SUSP REMOVE PRIOR AUTHORIZATION 
COLLATYL WOUND GEL ADD DRUGS 
COMBIGAN 0.2%-0.5% EYE DROPS MOVE DRUG TO LOWER TIER 
COSENTYX 150 MG/ML SYRINGE MOVE DRUG TO LOWER TIER 
COSENTYX 300 MG DOSE-2 PENS MOVE DRUG TO LOWER TIER 
CRESTOR REMOVE DRUGS 
CUTAQUIG 16.5% (1 G/6 ML) VIAL ADD DRUGS 
CUTAQUIG 16.5% (1.65 G/10 ML) ADD DRUGS 
CUTAQUIG 16.5% (2 G/12 ML) VL ADD DRUGS 
CUTAQUIG 16.5% (3.3 G/20 ML) ADD DRUGS 
CUTAQUIG 16.5% (4 G/24 ML) VL ADD DRUGS 
CUTAQUIG 16.5% (8 G/48 ML) VL ADD DRUGS 
DAURISMO ADD PRIOR AUTHORIZATION 
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DEFERASIROX 125 MG TABLET ADD DRUGS 
DEFERASIROX 250 MG TABLET ADD DRUGS 
DEFERASIROX 500 MG TABLET ADD DRUGS 
DELZICOL 400MG MOVE DRUG TO HIGHER TIER 
DELZICOL 400MG TAB MOVE DRUG TO HIGHER TIER 
DEXCOM G4 TRANSMITTER KIT MOVE DRUG TO HIGHER TIER 
DEXCOM G5 TRANSMITTER KIT MOVE DRUG TO HIGHER TIER 
DEXCOM G6 SENSOR ADD DRUGS 
DEXCOM G6 TRANSMITTER MOVE DRUG TO HIGHER TIER 
DEXMEDETOMIDIN 400MCG/100ML-NS ADD DRUGS 
DEXMEDETOMIDINE 200MCG/50ML-NS ADD DRUGS 
DEXMEDETOMIDINE 80 MCG/20ML-NS ADD DRUGS 
DEXTENZA 0.4 MG INSERT ADD DRUGS 
DIACOMIT ADD QUANTITY LIMIT 
DIACOMIT 250 MG CAPSULE ADD DRUGS 
DIACOMIT 250 MG POWDER PACKET ADD DRUGS 
DIACOMIT 500 MG CAPSULE ADD DRUGS 
DIACOMIT 500 MG POWDER PACKET ADD DRUGS 
DICLEGIS ADD PRIOR AUTHORIZATION 
DICLOFEX DC PACK ADD DRUGS 
DOVATO 50-300 MG TABLET ADD DRUGS 
DULERA DECREASE QUANTITY LIMIT 
DUOBRII 0.01%-0.045% LOTION ADD DRUGS 
DXEVO 11 DAY 1.5 MG TABLET ADD DRUGS 
ELIDEL 1% CREAM MOVE DRUG TO HIGHER TIER 
ELIDEL 1% CREAM REMOVE DRUGS 
ELZONRIS ADD QUANTITY LIMIT 
EMGALITY 120 MG/ML PEN ADD DRUGS 
EMGALITY 120 MG/ML SYRINGE ADD DRUGS 
EPINEPHRINE 0.3 MG AUTO-INJECT REMOVE PRIOR AUTHORIZATION 
EPINEPHRINE 0.3MG AUTO-INJECT ADD DRUGS 
EPINEPHRINE 1 MG/10 ML-NACL ADD DRUGS 
ERLOTINIB HCL 100 MG TABLET ADD DRUGS 
ERLOTINIB HCL 150 MG TABLET ADD DRUGS 
ERLOTINIB HCL 25 MG TABLET ADD DRUGS 
ERYPED SUSPENSION 400MG/5ML MOVE DRUG TO HIGHER TIER 
ERYTHROMYCIN 400 MG/5 ML SUSP ADD DRUGS 
ESTRADIOL HEMIHYDRATE MICR PWD ADD DRUGS 
EVENITY ADD PRIOR AUTHORIZATION 
EVENITY ADD QUANTITY LIMIT 
EVENITY 105 MG/1.17 ML SYRINGE ADD DRUGS 
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EVENITY 210 MG DOSE-2 SYRINGES ADD DRUGS 
EXEMESTANE 25 MG TABLET REMOVE PRIOR AUTHORIZATION 
EXJADE 125MG MOVE DRUG TO HIGHER TIER 
EXJADE 250MG MOVE DRUG TO HIGHER TIER 
EXJADE 500MG MOVE DRUG TO HIGHER TIER 
FARESTON 60 MG REMOVE DRUGS 
FARESTON 60 MG TABLET MOVE DRUG TO HIGHER TIER 
FARESTON 60 MG TABLET REMOVE DRUGS 
FINACEA 15% GEL MOVE DRUG TO HIGHER TIER 
FINACEA 15% GEL REMOVE DRUGS 
FLECTOR 1.3% PATCH MOVE DRUG TO HIGHER TIER 
FLOVENT 100 MCG DISKUS ADD DRUGS 
FLOVENT 250 MCG DISKUS ADD DRUGS 
FLOVENT 50 MCG DISKUS ADD DRUGS 
FLOVENT HFA DECREASE QUANTITY LIMIT 
FLOVENT HFA 110 MCG INHALER ADD DRUGS 
FLOVENT HFA 220 MCG INHALER ADD DRUGS 
FLOVENT HFA 44 MCG INHALER ADD DRUGS 
FLUTICASONE PROPIONATE/SALMETEROL DECREASE QUANTITY LIMIT 
FONDAPARINUX 2.5 MG, 5 MG, 7.5 MG, 10 MG/0.5 ML SYR REMOVE PRIOR AUTHORIZATION 
FREESTYLE LIBRE 10 DAY SENSOR ADD DRUGS 
FREESTYLE LIBRE 14 DAY SENSOR ADD DRUGS 
FULPHILA 6 MG/0.6 ML SYRINGE ADD DRUGS 
GAMIFANT ADD PRIOR AUTHORIZATION 
GELCLAIR REMOVE DRUGS 
GENVOYA ADD STEP THERAPY 
GLEOLAN 1,500 MG/50 ML SOLN ADD DRUGS 
HEALON 10 MG/ML SYRINGE ADD DRUGS 
HEALON GV 14 MG/ML SYRINGE ADD DRUGS 
HEALON5 23 MG/ML SYRINGE ADD DRUGS 
HEALTHWISE INS 0.3ML 30GX5/16" ADD DRUGS 
HEALTHWISE INS 0.3ML 31GX5/16" ADD DRUGS 
HEALTHWISE INS 0.5ML 30GX5/16" ADD DRUGS 
HEALTHWISE INS 0.5ML 31GX5/16" ADD DRUGS 
HEALTHWISE INS 1 ML 30GX5/16" ADD DRUGS 
HEALTHWISE INS 1 ML 31GX5/16" ADD DRUGS 
HEALTHWISE PEN NEEDLE 31G 5MM ADD DRUGS 
HEPARIN SOD 5,000 UNIT/0.5 ML ADD DRUGS 
HERCEPTIN HYLECTA 600MG-10,000 ADD DRUGS 
HYDROCORT-PRAMOXINE 2.5-1% CRM ADD DRUGS 
IMIQUIMOD DECREASE QUANTITY LIMIT 
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INFUGEM 1,200 MG/120 ML BAG ADD DRUGS 
INFUGEM 1,300 MG/130 ML BAG ADD DRUGS 
INFUGEM 1,400 MG/140 ML BAG ADD DRUGS 
INFUGEM 1,500 MG/150 ML BAG ADD DRUGS 
INFUGEM 1,600 MG/160 ML BAG ADD DRUGS 
INFUGEM 1,700 MG/170 ML BAG ADD DRUGS 
INFUGEM 1,800 MG/180 ML BAG ADD DRUGS 
INFUGEM 1,900 MG/190 ML BAG ADD DRUGS 
INFUGEM 2,000 MG/200 ML BAG ADD DRUGS 
INFUGEM 2,200 MG/220 ML BAG ADD DRUGS 
INGREZZA INITIATION PACK ADD DRUGS 
INSULIN LISPRO 100 UNIT/ML PEN ADD DRUGS 
INSULIN LISPRO 100 UNIT/ML VL ADD DRUGS 
JORNAY PM 100 MG CAPSULE ADD DRUGS 
JORNAY PM 20 MG CAPSULE ADD DRUGS 
JORNAY PM 40 MG CAPSULE ADD DRUGS 
JORNAY PM 60 MG CAPSULE ADD DRUGS 
JORNAY PM 80 MG CAPSULE ADD DRUGS 
JYNARQUE 15 MG TABLET ADD DRUGS 
JYNARQUE 30 MG TABLET ADD DRUGS 
KALYDECO 25 MG GRANULES PACKET ADD DRUGS 
KETAMINE 50 MG/ML-WATER SYRING ADD DRUGS 
KETOCAL 2.5:1 MCT MULTIFIBR LQ ADD DRUGS 
L.E.T.(LIDO-EPINEPH-TETRA) GEL ADD DRUGS 
LATUDA 20 MG TABLET MOVE DRUG TO LOWER TIER 
LATUDA 40 MG TABLET MOVE DRUG TO LOWER TIER 
LATUDA 60 MG TABLET MOVE DRUG TO LOWER TIER 
LATUDA 80 MG TABLET MOVE DRUG TO LOWER TIER 
LETAIRIS 10MG REMOVE DRUGS 
LETAIRIS 5MG REMOVE DRUGS 
LEVETIRACETAM ER 500 MG, 750 MG REMOVE PRIOR AUTHORIZATION 
LEXAPRO ADD STEP THERAPY 
LEXAPRO REMOVE DRUGS 
LIALDA ADD STEP THERAPY 
LIALDA REMOVE DRUGS 
LORBRENA ADD PRIOR AUTHORIZATION 
LORBRENA ADD QUANTITY LIMIT 
LOTEPREDNOL ETABONATE 0.5% DRP ADD DRUGS 
LUMIGAN 0.01% EYE DROPS MOVE DRUG TO LOWER TIER 
MAGNESIUM 20 GRAM/290 ML-LR ADD DRUGS 
MAVENCLAD ADD PRIOR AUTHORIZATION 
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MAVENCLAD 10 MG X 10 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 4 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 5 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 6 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 7 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 8 TABLET PK ADD DRUGS 
MAVENCLAD 10 MG X 9 TABLET PK ADD DRUGS 
MAYZENT ADD PRIOR AUTHORIZATION 
MAYZENT 0.25 MG TABLET ADD DRUGS 
MAYZENT 2 MG TABLET ADD DRUGS 
MESALAMINE DR 400 MG CAPSULE ADD DRUGS 
MESTINON 60 MG/5 ML SYRUP MOVE DRUG TO HIGHER TIER 
MESTINON 60 MG/5 ML SYRUP REMOVE DRUGS 
METHOXSALEN 10 MG REMOVE PRIOR AUTHORIZATION 
MIFEPRISTONE 200 MG TABLET ADD DRUGS 
M-NATAL PLUS TABLET ADD DRUGS 
MOTEGRITY 2 MG TABLET ADD DRUGS 
MULPLETA ADD PRIOR AUTHORIZATION 
NEUPOGEN 300 MCG/0.5 ML SYR REMOVE DRUGS 
NEUPOGEN 300 MCG/ML VIAL REMOVE DRUGS 
NEUPOGEN 480 MCG/0.8 ML SYR REMOVE DRUGS 
NEUPOGEN 480 MCG/1.6 ML VIAL REMOVE DRUGS 
NOCDURNA ADD QUANTITY LIMIT 
NORDITROPIN FLEXPRO 10 MG/1.5 ADD DRUGS 
NORDITROPIN FLEXPRO 30 MG/3 ML ADD DRUGS 
NORDITROPIN FLEXPRO 5 MG/1.5 ADD DRUGS 
NORGESIC FORTE  50-770-60MG TB ADD DRUGS 
NUZYRA ADD QUANTITY LIMIT 
ODACTRA 12 SQ-HDM SL TABLET ADD DRUGS 
OFEV 150 MG CAPSULE MOVE DRUG TO LOWER TIER 
ONETOUCH ULTRA2 GLUCOSE SYST ADD DRUGS 
OXERVATE ADD PRIOR AUTHORIZATION 
OXERVATE ADD STEP THERAPY 
PALONOSETRON HCL 0.25 MG/5 ML ADD DRUGS 
PALONOSETRON HCL 0.25 MG/5 ML MOVE DRUG TO LOWER TIER 
PENICILLAMINE 250 MG CAPSULE ADD DRUGS 
PENTAMIDINE 300 MG VIAL ADD DRUGS 
PLENAMINE 15% SOLUTION ADD DRUGS 
PRILOVIX LITE 2.5%-2.5% CREAM ADD DRUGS 
PRISTIQ REMOVE DRUGS 
PROGRAF 0.2 MG GRANULE PACKET ADD DRUGS 
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PROGRAF 1 MG GRANULE PACKET ADD DRUGS 
PROTYL AG WOUND GEL ADD DRUGS 
QMIIZ ODT ADD PRIOR AUTHORIZATION 
QMIIZ ODT ADD STEP THERAPY 
RANEXA 500 MG REMOVE DRUGS 
RANEXA ER 1,000 MG TABLET MOVE DRUG TO HIGHER TIER 
RANEXA ER 1,000 MG TABLET REMOVE DRUGS 
RANEXA ER 500 MG TABLET MOVE DRUG TO HIGHER TIER 
RANEXA ER 500 MG TABLET REMOVE DRUGS 
RAPAFLO 4 MG, 8 MG REMOVE DRUGS 
RAPAMUNE 1 MG/ML ORAL SOLN MOVE DRUG TO HIGHER TIER 
RAPAMUNE 1 MG/ML ORAL SOLN REMOVE DRUGS 
RAPAMUNE 1 MG/ML ORAL SOLUTION REMOVE DRUGS 
REMODULIN 1 MG/ML VIAL REMOVE DRUGS 
REMODULIN 1 MG/ML, 2.5 MG/ML, 5 MG/ML, 10 MG/ML REMOVE DRUGS 
REMODULIN 10 MG/ML VIAL REMOVE DRUGS 
REMODULIN 2.5 MG/ML VIAL REMOVE DRUGS 
REMODULIN 5 MG/ML VIAL REMOVE DRUGS 
RESOTRA RX REMOVE DRUGS 
RETACRIT 10,000 UNIT/ML VIAL ADD DRUGS 
RETACRIT 2,000 UNIT/ML VIAL ADD DRUGS 
RETACRIT 3,000 UNIT/ML VIAL ADD DRUGS 
RETACRIT 4,000 UNIT/ML VIAL ADD DRUGS 
RETACRIT 40,000 UNIT/ML VIAL ADD DRUGS 
REVCOVI ADD PRIOR AUTHORIZATION 
ROCKLATAN 0.02%-0.005% EYE DRP ADD DRUGS 
ROCURONIUM 75 MG/7.5 ML SYRING ADD DRUGS 
SCARCIN ROLL ON REMOVE DRUGS 
SCARSILK 5 CM X 14 CM PAD ADD DRUGS 
SCARSILK GEL ADD DRUGS 
SENSIPAR 30 MG TABLET REMOVE DRUGS 
SENSIPAR 30 MG, 60 MG, 90 MG REMOVE DRUGS 
SENSIPAR 60 MG TABLET REMOVE DRUGS 
SENSIPAR 90 MG TABLET REMOVE DRUGS 
SEYSARA ADD PRIOR AUTHORIZATION 
SIMLIYA 28 DAY TABLET ADD DRUGS 
SKYRIZI ADD PRIOR AUTHORIZATION 
SOFOSBUVIR-VELPATASVIR 400-100 ADD DRUGS 
SOFOSBUVIR-VELPATASVIR 400-100MG TABLET (GENERIC 
EPCLUSA) 
ADD DRUGS 
SOLIFENACIN 10 MG TABLET ADD DRUGS 
SOLIFENACIN 5 MG TABLET ADD DRUGS 
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SOLOX WOUND GEL ADD DRUGS 
SOOLANTRA 1% CREAM MOVE DRUG TO LOWER TIER 
STERILE DILUENT-TREPROSTINIL ADD DRUGS 
STRONG IODINE 7% TINCTURE ADD DRUGS 
SUBLOCADE REMOVE PRIOR AUTHORIZATION 
SUBOXONE 12 MG-3 MG SL FILM MOVE DRUG TO HIGHER TIER 
SUBOXONE 12 MG-3 MG SL FILM REMOVE DRUGS 
SUBOXONE 2 MG-0.5 MG SL FILM MOVE DRUG TO HIGHER TIER 
SUBOXONE 2 MG-0.5 MG SL FILM REMOVE DRUGS 
SUBOXONE 4 MG-1 MG SL FILM MOVE DRUG TO HIGHER TIER 
SUBOXONE 4 MG-1 MG SL FILM REMOVE DRUGS 
SUBOXONE 8 MG-2 MG SL FILM MOVE DRUG TO HIGHER TIER 
SUBOXONE 8 MG-2 MG SL FILM REMOVE DRUGS 
SYMFI 600-300-300 MG TABLET ADD DRUGS 
SYMFI 600-300-300 MG TABLET MOVE DRUG TO LOWER TIER 
SYMFI LO 400-300-300 MG TABLET ADD DRUGS 
SYMFI LO 400-300-300 MG TABLET MOVE DRUG TO LOWER TIER 
SYMJEPI 0.3 MG/0.3 ML SYRINGE ADD DRUGS 
SYMJEPI 0.3MG/0.3ML SYRINGE ADD DRUGS 
TARCEVA 100MG MOVE DRUG TO HIGHER TIER 
TARCEVA 150MG MOVE DRUG TO HIGHER TIER 
TARCEVA 25MG MOVE DRUG TO HIGHER TIER 
TARINA 24 FE 1 MG-20 MCG TAB ADD DRUGS 
TECENTRIQ 840 MG/14 ML VIAL ADD DRUGS 
TEKTURNA 150 MG, 300 MG TABLET REMOVE DRUGS 
TERBINAFINE 25 MG TABLET REMOVE PRIOR AUTHORIZATION 
TRACLEER 125MG MOVE DRUG TO HIGHER TIER 
TREMFYA 100 MG/ML SYRINGE MOVE DRUG TO LOWER TIER 
VALRUBICIN 200 MG/5 ML VIAL ADD DRUGS 
VANCOMYCIN 1,250 MG/12.5 ML VL ADD DRUGS 
VANCOMYCIN 1,500 MG/15ML-WATER ADD DRUGS 
VANCOMYCIN 1,750 MG/17.5 ML VL ADD DRUGS 
VANCOMYCIN 2,000 MG/20ML-WATER ADD DRUGS 
VESICARE 10MG MOVE DRUG TO HIGHER TIER 
VESICARE 10MG TAB MOVE DRUG TO HIGHER TIER 
VESICARE 5MG MOVE DRUG TO HIGHER TIER 
VESICARE 5MG TAB MOVE DRUG TO HIGHER TIER 
VIVITROL ADD QUANTITY LIMIT 
VSL #3 DS REMOVE DRUGS 
VYNDAQEL ADD QUANTITY LIMIT 
VYNDAQEL 20 MG CAPSULE ADD DRUGS 
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VYVANSE 20 MG CHEWABLE TABLET REMOVE PRIOR AUTHORIZATION 
XELJANZ 10 MG TABLET MOVE DRUG TO LOWER TIER 
XELJANZ 5 MG TABLET MOVE DRUG TO LOWER TIER 
XELJANZ XR 11 MG TABLET MOVE DRUG TO LOWER TIER 
XIFAXAN 200 MG TABLET MOVE DRUG TO LOWER TIER 
XIFAXAN 550 MG TABLET MOVE DRUG TO LOWER TIER 
ZARXIO 300 MCG/0.5 ML SYRINGE ADD DRUGS 
ZARXIO 480 MCG/0.8 ML SYRINGE ADD DRUGS 
ZILEUTON ER 600 MG TABLET REMOVE PRIOR AUTHORIZATION 
ZYKADIA 150 MG TABLET ADD DRUGS 
ZYTIGA 250 MG TABLET MOVE DRUG TO HIGHER TIER 
ZYTIGA 250 MG TABLET REMOVE DRUGS 
Table 9:  Number of affected enrollees by drug name Q2 2019: 
Drug Name Affected Enrollees 
ADDERALL XR 1 
ADVAIR 100-50 DISKUS 299 
ADVAIR 100-50, 250-50 DISKUS 93 
ADVAIR 250-50 DISKUS 620 
ADVAIR 500-50 DISKUS 161 
AIMOVIG      INJ 140DOSE 1 
AIMOVIG      INJ 70MG/ML 1 
AIMOVIG 140 MG DOSE-2 AUTOINJ 12 
AIMOVIG 70 MG/ML AUTOINJECTOR 90 
ASMANEX TWISTHALER 2 
Avenova 1 
CANASA 1,000 MG SUPPOSITORY 17 
CARAFATE 1 GM/10 ML SUSP 39 
COMBIGAN 0.2%-0.5% EYE DROPS 72 
COSENTYX 150 MG/ML SYRINGE 3 
COSENTYX 300 MG DOSE-2 PENS 30 
CRESTOR 1 
Delzicol 400mg tab 14 
DEXCOM G6 SENSOR 75 
DEXCOM G6 TRANSMITTER 1 
DICLEGIS 1 
DULERA 4 
ELIDEL 1% CREAM 54 
Elzonris 0 
EMGALITY 120 MG/ML PEN 18 
14 
 
EMGALITY 120 MG/ML SYRINGE 3 
EPINEPHRINE 0.3 MG AUTO-INJECT 84 
FARESTON 60 MG TABLET 2 
FINACEA 15% GEL 60 
Flector 1.3% Patch 1 
FLOVENT 100 MCG DISKUS 12 
FLOVENT 250 MCG DISKUS 6 
FLOVENT 50 MCG DISKUS 3 
FLOVENT HFA 7 
FLOVENT HFA 110 MCG INHALER 204 
FLOVENT HFA 220 MCG INHALER 54 
FLOVENT HFA 44 MCG INHALER 132 
FLUTICASONE PROPIONATE/SALMETEROL 1 
FREESTYLE LIBRE 10 DAY SENSOR 6 
FREESTYLE LIBRE 14 DAY SENSOR 120 
GENVOYA 1 
IMIQUIMOD 1 
LATUDA 20 MG TABLET 27 
LATUDA 40 MG TABLET 33 
LATUDA 60 MG TABLET 30 
LATUDA 80 MG TABLET 24 
Letairis 10mg 0 
LEXAPRO 4 
LIALDA 2 
LUMIGAN 0.01% EYE DROPS 45 
MAGNESIUM 20 GRAM/290 ML-LR 0 
MOTEGRITY 2 MG TABLET 9 
NEUPOGEN 480 MCG/0.8 ML SYR 2 
NORDITROPIN FLEXPRO 10 MG/1.5 3 
NORDITROPIN FLEXPRO 30 MG/3 ML 3 
NORDITROPIN FLEXPRO 5 MG/1.5 3 
ODACTRA 12 SQ-HDM SL TABLET 3 
OFEV 150 MG CAPSULE 3 
PRISTIQ 1 
RANEXA 500 MG 2 
RANEXA ER 1,000 MG TABLET 12 
RANEXA ER 500 MG TABLET 25 
RAPAFLO 4 MG, 8 MG 1 
SENSIPAR 30 MG, 60 MG, 90 MG 2 
SOOLANTRA 1% CREAM 21 
SUBOXONE 12 MG-3 MG SL FILM 6 
15 
 
SUBOXONE 2 MG-0.5 MG SL FILM 21 
SUBOXONE 4 MG-1 MG SL FILM 7 
SUBOXONE 8 MG-2 MG SL FILM 115 
TREMFYA 100 MG/ML SYRINGE 9 
Vesicare 10mg tab 16 
Vesicare 5mg tab 15 
VYVANSE 20 MG CHEWABLE TABLET 3 
XELJANZ 10 MG TABLET 6 
XELJANZ 5 MG TABLET 18 
XELJANZ XR 11 MG TABLET 27 
XIFAXAN 200 MG TABLET 6 
XIFAXAN 550 MG TABLET 72 
ZYTIGA 250 MG TABLET 3 
TOTAL 2886 
Table 10:  Number of exceptions made by drug name Q2 2019:   
Drug Name Granted Denied Withdrawn Total 
Exception 
Requests 
ADDERALL XR 1 0 0 1 
ADVAIR 100-50 DISKUS 1 0 0 1 
AIMOVIG      INJ 140DOSE 1 0 0 1 
AIMOVIG      INJ 70MG/ML 0 0 1 1 
AIMOVIG 140 MG DOSE-2 AUTOINJ 9 6 0 15 
AIMOVIG 70 MG/ML AUTOINJECTOR 12 3 0 15 
COSENTYX 300 MG DOSE-2 PENS 12 0 0 12 
DICLEGIS 1 0 0 1 
ELIDEL 1% CREAM 2 0 0 2 
EMGALITY 120 MG/ML PEN 3 12 0 15 
EMGALITY 120 MG/ML SYRINGE 3 0 0 3 
FREESTYLE LIBRE 10 DAY SENSOR 3 0 0 3 
FREESTYLE LIBRE 14 DAY SENSOR 6 3 0 9 
LEXAPRO 4 0 0 4 
LIALDA 2 0 0 2 
MOTEGRITY 2 MG TABLET 3 0 0 3 
NEUPOGEN 300 MCG/0.5 ML SYR 2 0 0 2 
16 
 
NEUPOGEN 300 MCG/ML VIAL 1 0 0 1 
NEUPOGEN 480 MCG/0.8 ML SYR 1 2 0 3 
NORDITROPIN FLEXPRO 10 MG/1.5 3 3 0 6 
NORDITROPIN FLEXPRO 30 MG/3 ML 3 3 0 6 
OFEV 150 MG CAPSULE 0 3 0 3 
VYVANSE 20 MG CHEWABLE TABLET 3 3 0 6 
XELJANZ 10 MG TABLET 3 0 0 3 
XELJANZ XR 11 MG TABLET 6 3 0 9 
ZYTIGA 250 MG TABLET 1 0 0 1 
TOTAL 102 48 1 151 
 
 
 
